Correlation Between Agios Pharm and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Agios Pharm and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Lipella Pharmaceuticals.
Diversification Opportunities for Agios Pharm and Lipella Pharmaceuticals
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Agios and Lipella is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Agios Pharm i.e., Agios Pharm and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Agios Pharm and Lipella Pharmaceuticals
Given the investment horizon of 90 days Agios Pharm is expected to generate 8.97 times less return on investment than Lipella Pharmaceuticals. But when comparing it to its historical volatility, Agios Pharm is 12.32 times less risky than Lipella Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 272.00 in Lipella Pharmaceuticals Common on November 27, 2024 and sell it today you would earn a total of 28.00 from holding Lipella Pharmaceuticals Common or generate 10.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Agios Pharm |
| Lipella Pharmaceuticals |
Agios Pharm and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and Lipella Pharmaceuticals
The main advantage of trading using opposite Agios Pharm and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |